Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 1:45 AM UTC
| NCT Number | NCT07621718 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer |
| Phase | PHASE3 |
| Target Enrollment | 670 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | August 21, 2026 (1 week ago) |
As of September 2, 2026: Clinical trial NCT07621718 is currently recruiting participants. This phase3 study for pancreatic cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07621718 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07621718 was last updated 1 week ago (August 21, 2026). HelloStudys verifies this status automatically.